Dermatological manifestations of palifermin therapy: a common side effect of its use in oncology
- PMID: 22673739
- DOI: 10.4161/cbt.20566
Dermatological manifestations of palifermin therapy: a common side effect of its use in oncology
Comment on
-
Non-invasive detection of a palifermin-mediated adaptive response following chemotherapy-induced damage to the distal small intestine of rats.Cancer Biol Ther. 2011 Sep 1;12(5):399-406. doi: 10.4161/cbt.12.5.15977. Epub 2011 Sep 1. Cancer Biol Ther. 2011. PMID: 21705855
Similar articles
-
Non-invasive detection of a palifermin-mediated adaptive response following chemotherapy-induced damage to the distal small intestine of rats.Cancer Biol Ther. 2011 Sep 1;12(5):399-406. doi: 10.4161/cbt.12.5.15977. Epub 2011 Sep 1. Cancer Biol Ther. 2011. PMID: 21705855
-
Palifermin as treatment in dose-intense conventional polychemotherapy induced mucositis.Haematologica. 2006 Aug;91(8 Suppl):ECR32. Haematologica. 2006. PMID: 16923516
-
Role of palifermin in fluorouracil-based therapy for metastatic colorectal cancer.J Clin Oncol. 2008 Mar 10;26(8):1386-7. doi: 10.1200/JCO.2007.15.4492. J Clin Oncol. 2008. PMID: 18323563 No abstract available.
-
Palifermin: a keratinocyte growth factor that reduces oral mucositis after stem cell transplant for haematological malignancies.Expert Opin Pharmacother. 2006 Nov;7(16):2287-99. doi: 10.1517/14656566.7.16.2287. Expert Opin Pharmacother. 2006. PMID: 17059384 Review.
-
Keratinocyte growth factor.Expert Opin Biol Ther. 2009 Jun;9(6):779-87. doi: 10.1517/14712590902976837. Expert Opin Biol Ther. 2009. PMID: 19456212 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources